Skip to main content

Articles

Page 7 of 16

  1. To asses the retinal pigment epithelium (RPE) function measured by EOG testing in patients with neurofibromatosis type 1 (NF-1). Our preliminary EOG results suggested dysfunction of the RPE in individuals with...

    Authors: Wojciech Lubiński, Stanisław Zajączek, Zbigniew Sych, Krzysztof Penkala, Olgierd Palacz and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2004 2:193
  2. Gastric cancer is the second most frequently diagnosed malignancy worldwide and therefore represents a significant healthcare burden. Environmental and genetic factors are involved in the development of gastri...

    Authors: Beata Gawdis-Wojnarska, Marek Brzosko, Jacek Fliciński, Krzysztof Marlicz, Teresa Starzyńska, Rodney J Scott and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2004 2:65
  3. Authors: Sandra Costa and Fernando C Schmitt
    Citation: Hereditary Cancer in Clinical Practice 2008 6:64
  4. BRCA1 and BRCA2 germ-line mutations occur in a significant number of unselected ovarian cancer (OC) patients, thus making a noticeable contribution to OC morbidity. It is of interest whether CHEK2, which is frequ...

    Authors: Nadezhda Yu Krylova, Daria N Ponomariova, Natalia Yu Sherina, Natalia Yu Ogorodnikova, Denis A Logvinov, Natalia V Porhanova, Oksana S Lobeiko, Adel F Urmancheyeva, Sergey Ya Maximov, Alexandr V Togo, Evgeny N Suspitsin and Evgeny N Imyanitov
    Citation: Hereditary Cancer in Clinical Practice 2007 5:153
  5. Authors: T T Huzarski, B Górecka-Szyld, J J Huzarska, G Psut, G Wilk, R Sibilski, C Cybulski, B Kozak-Klonowska, M Siołek, E Kilar, D Czudowska, H Janiszewska, D Godlewski, A Mackiewicz, J Jarkiewicz-Tretyn, I Szabo-Moskal…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A18

    This article is part of a Supplement: Volume 10 Supplement 4

  6. Authors: Jonathan Beesley, Hilda Pickett, Sharon Johnatty, Xiaoqing Chen, Jun Jun Li, David Rider, Michael Stutz, Diether Lambrecht, Jenny Chang-Claude, Thilo Dork, Marc Goodman, Bart Kiemmney, Elisa Bandera, Linda Kelemen, Shan Wang-Gorke, Ian Campbell…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A86

    This article is part of a Supplement: Volume 10 Supplement 2

  7. Authors: Marcin Lener, Anna Wiechowska-Kozlowska, Rodney J Scott, Magdalena Muszynska, Jozef Kladny, Piotr Waloszczyk, Anna Rutkowska, Grzegorz Sukiennicki, Tomasz Gromowski, Katarzyna Jaworska-Bieniek, Thierry van de Wetering, Katarzyna Kaczmarek, Anna Jakubowska and Jan Lubinski
    Citation: Hereditary Cancer in Clinical Practice 2015 13(Suppl 1):A14

    This article is part of a Supplement: Volume 13 Supplement 1

  8. Authors: Andrzej Plawski, Paweł Boruń, Tomasz Banasiewicz, Jacek Paszkowski, Agnieszka Stembalska, Maria Sąsiadek, Monika Siołek, Beata Kozak - Klonowska, Izabela Brozek, Janusz Limon, Dorota Nowakowska, Grzegorz Kurzawski, Tomasz Byrski, Tomasz Gach, Diana Hodorowicz-Zaniewska, Anna Bartkowiak…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A24

    This article is part of a Supplement: Volume 10 Supplement 4

  9. Authors: Urszula Teodorczyk, Cezary Cybulski, Anna Jakubowska, Teresa Starzyńska, Małgorzata Ławniczak, Paweł Domagała, Katarzyna Ferenc, Krzysztof Marlicz, Zbigniew Banaszkiewicz, Rafał Wiśniowski and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 3):A22

    This article is part of a Supplement: Volume 10 Supplement 3

  10. Men who carry mutations in BRCA1 or BRCA2 are at increased risk for prostate cancer. However the efficacy of prostate screening in this setting is uncertain and limited data exists on the uptake of prostate scree...

    Authors: Joanne M McKinley, Prue C Weideman, Mark A Jenkins, Michael L Friedlander, John L Hopper, Sue-Anne McLachlan, Geoffrey J Lindeman, kConFab Investigators and Kelly-Anne Phillips
    Citation: Hereditary Cancer in Clinical Practice 2007 5:161
  11. In addition to a relatively small number of well known hereditary cancer syndromes, hundreds of presumed or proven hereditary disorders have been observed to manifest cancer as a characteristic feature or as a...

    Authors: Rolf H. Sijmons and Gerard T.N. Burger
    Citation: Hereditary Cancer in Clinical Practice 2003 1:31
  12. The effectiveness of a genetics-based public health screening programs depend on the successful recruitment of subjects who qualify for intensified screening by virtue of a positive genetic test. Herein we com...

    Authors: Anna Galor, Cezary Cybulski, Jan Lubiński, Steven A Narod and Jacek Gronwald
    Citation: Hereditary Cancer in Clinical Practice 2013 11:17
  13. This paper highlights the need for carriers to be followed up by health professionals who understand the complexities of the BRCA syndrome. A BRCA carrier clinic has been established in London and regular follow ...

    Authors: Audrey Ardern-Jones and Rosalind Eeles
    Citation: Hereditary Cancer in Clinical Practice 2004 2:77
  14. Authors: Katrzyna Jaworska-Bieniek, Satish Gupta, Katarzyna Durda, Magdalena Muszynska, Grzegorz Sukiennicki, Elżbieta Jaworowska, Tomasz Grodzki, Mieczysław Sulikowski, Piotr Woloszczyk, Janusz Wójcik, Jakub Lubiński, Cezary Cybulski, Tadeusz Dębniak, Marcin Lener, Steven A Narod, Ping Sun…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A2

    This article is part of a Supplement: Volume 10 Supplement 4

  15. Authors: Katarzyna Jaworska - Bieniek, Anna Jakubowska, Katarzyna Durda, Tomasz Huzarski, Pablo Serrano-Fernandez, Grzegorz Sukiennicki, Magdalena Muszyńska, Tomasz Byrski, Jacek Gronwald, Satish Gupta, Katarzyna Kaczmarek and Jan Lubiński
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 4):A4

    This article is part of a Supplement: Volume 10 Supplement 4

  16. Authors: Bente A Talseth-Palmer, Juul T Wijnen, Ingvild S Brenne, Shantie Jagmohan-Changur, Katie A Ashton, Carli M Tops, Tiffany-Jane Evans, Mary McPhillips, Claire Groombridge, Janina Suchy, Grzegorz Kurzawski, Allan Spigelman, Pål Møller, Hans M Morreau, Tom Van Wezel, Jan Lubinski…
    Citation: Hereditary Cancer in Clinical Practice 2012 10(Suppl 2):A32

    This article is part of a Supplement: Volume 10 Supplement 2

  17. It has not been established whether CHEK2 and NOD2 variants are present in Latvia and whether inherited variation in these genes influences cancer risk in this population.

    Authors: Arvids Irmejs, Edvins Miklasevics, Viktors Boroschenko, Andris Gardovskis, Andrejs Vanags, Inga Melbarde-Gorkusa, Marianna Bitina, Janina Suchy and Janis Gardovskis
    Citation: Hereditary Cancer in Clinical Practice 2006 4:48
  18. Authors: Tadeusz Dębniak, Cezary Cybulski, Grzegorz Kurzawski, Bohdan Górski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Janina Suchy, Bartłomiej Masojć, Marek Mierzejewski, Marcin Lener, Urszula Teodorczyk, Krzysztof Mędrek, Elżbieta Złowocka, Ewa Grabowska-Kłujszo, Katarzyna Nej-Wołosiak…
    Citation: Hereditary Cancer in Clinical Practice 2006 4:52
  19. The frameshift NOD2 gene mutation 3020insC is predominantly associated with Crohn's disease, but predisposes to many types of common cancers as well. We studied the frequency of this mutant NOD2 allele in 148 bre...

    Authors: Hanna Janiszewska, Olga Haus, Anna Lauda-Świeciak, Aneta Bąk, Tomasz Mierzwa, Jan Sir and Ryszard Laskowski
    Citation: Hereditary Cancer in Clinical Practice 2006 4:15

Annual Journal Metrics

  • 2022 Citation Impact
    1.7 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    0.634 - SNIP (Source Normalized Impact per Paper)
    0.526 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    131 days submission to accept (Median)

    2023 Usage 
    394,813 downloads
    196 Altmetric mentions